- Home
- IDA vs AXSM Comparison
IDA vs AXSM Comparison
Compare IDA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDA
- AXSM
- Stock Information
- Founded
- IDA 1915
- AXSM 2012
- Country
- IDA United States
- AXSM United States
- Employees
- IDA N/A
- AXSM N/A
- Industry
- IDA Electric Utilities: Central
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- IDA Utilities
- AXSM Health Care
- Exchange
- IDA Nasdaq
- AXSM Nasdaq
- Market Cap
- IDA 6.1B
- AXSM 6.3B
- IPO Year
- IDA N/A
- AXSM 2015
- Fundamental
- Price
- IDA $114.93
- AXSM $118.53
- Analyst Decision
- IDA Buy
- AXSM Strong Buy
- Analyst Count
- IDA 6
- AXSM 14
- Target Price
- IDA $120.50
- AXSM $168.93
- AVG Volume (30 Days)
- IDA 308.7K
- AXSM 567.5K
- Earning Date
- IDA 05-01-2025
- AXSM 05-05-2025
- Dividend Yield
- IDA 2.99%
- AXSM N/A
- EPS Growth
- IDA 7.00
- AXSM N/A
- EPS
- IDA 5.50
- AXSM N/A
- Revenue
- IDA $1,826,633,000.00
- AXSM $385,693,000.00
- Revenue This Year
- IDA $8.34
- AXSM $65.06
- Revenue Next Year
- IDA $7.28
- AXSM $63.84
- P/E Ratio
- IDA $20.82
- AXSM N/A
- Revenue Growth
- IDA 3.41
- AXSM 42.53
- 52 Week Low
- IDA $88.70
- AXSM $64.11
- 52 Week High
- IDA $120.42
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- IDA 52.81
- AXSM 44.34
- Support Level
- IDA $111.41
- AXSM $117.60
- Resistance Level
- IDA $117.31
- AXSM $130.20
- Average True Range (ATR)
- IDA 1.76
- AXSM 4.27
- MACD
- IDA -0.29
- AXSM -1.09
- Stochastic Oscillator
- IDA 59.66
- AXSM 7.38
About IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.